So far, methylation of SLC6A5 (also known as the glycine transporter gene GLYT2) was associated with glioma [69], prostate cancer [70, 71], oral and pharyngeal cancer [72]; and the expression was down-regulated during rat liver regeneration [73]. This evidence concerns the gene SLC6A5 and pharynx cancer.